BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:08 PM
 | 
Jun 11, 2008
 |  BC Extra  |  Company News

Pierre submits milnacipran MAA, reports Phase III data

Pierre Fabre (Castres, France) said on Wednesday that it recently submitted an MAA to EMEA for milnacipran to treat fibromyalgia syndrome. The company also said the norepinephrine and serotonin reuptake inhibitor (NSRI) significantly improved...

Read the full 154 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >